| Literature DB >> 29237702 |
Braveen B Joseph1, Nicolas A Blouin2,1, David S Fay3.
Abstract
Whole-genome sequencing (WGS) is an indispensable tool for identifying causal mutations obtained from genetic screens. To reduce the number of causal mutation candidates typically uncovered by WGS, Caenorhabditis elegans researchers have developed several strategies. One involves crossing N2-background mutants to the polymorphic Hawaiian (HA) strain, which can be used to simultaneously identify mutant strain variants and obtain high-density mapping information. This approach, however, is not well suited for uncovering mutations in complex genetic backgrounds, and HA polymorphisms can alter phenotypes. Other approaches make use of DNA variants present in the initial background or introduced by mutagenesis. This information is used to implicate genomic regions with high densities of DNA lesions that persist after backcrossing, but these methods can provide lower resolution than HA mapping. To identify suppressor mutations using WGS, we developed an approach termed the sibling subtraction method (SSM). This method works by eliminating variants present in both mutants and their nonmutant siblings, thus greatly reducing the number of candidates. We used this method with two members of the C. elegans NimA-related kinase family, nekl-2 and nekl-3 Combining weak aphenotypic alleles of nekl-2 and nekl-3 leads to penetrant molting defects and larval arrest. We isolated ∼50 suppressors of nekl-2; nekl-3 synthetic lethality using F1 clonal screening methods and a peel-1-based counterselection strategy. When applied to five of the suppressors, SSM led to only one to four suppressor candidates per strain. Thus SSM is a powerful approach for identifying causal mutations in any genetic background and provides an alternative to current methods.Entities:
Keywords: C. elegans; NimA kinases; counterselection; peel-1; suppressor screens whole-genome sequencing
Mesh:
Substances:
Year: 2018 PMID: 29237702 PMCID: PMC5919755 DOI: 10.1534/g3.117.300135
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Strains used for sequencing analysis
| Strain Name | Allele | % Suppression ( | Dominant/Recessive | Autosome/LGX |
|---|---|---|---|---|
| WY1208 | 83 (223) | Recessive | LGX | |
| WY1209 | 87 (360) | Recessive | Autosome | |
| WY1210 | 50 (276) | Dominant | LGX | |
| WY1211 | 35 (422) | Recessive | Autosome | |
| WY1217 | 76 (235) | Recessive | LGX |
For details on genetic analyses see Materials and Methods.
Figure 1Phenotypes of molting-defective and suppressed strains. (A, C, and E) DIC and (B, D, and F) fluorescence images of strains WY1145 [nekl-2(fd81); nekl-3(gk894345)] and WY1211 [nekl-2(fd81); paa-1(fd134); nekl-3(gk894345)]. GFP+ worms carry an extrachromosomal array (fdEx286) that expresses wild-type nekl-3 and SUR-5::GFP. (A and B) Whereas GFP− worms (white arrows) in the starting strain, WY1145, arrest uniformly with molting defects. (C and D) GFP− worms in the suppressed strain, WY1211, can reach adulthood. (E and F) Suppression is reverted in strain WY1211 by the expression of wild-type paa-1 from a fosmid, which is carried by an independent extrachromosomal array marked with SUR-5::RFP. Compare GFP− RFP+ arrested larva (E and F) with GFP− gravid adults (C and D). Also note that the paa-1+ RFP-marked array is not generically deleterious for growth as evidenced by the viability of GFP+ RFP+ adults (E and F). White arrows indicate GFP− worms; white arrowheads indicate GFP+ worms; white boxes in (E) and (F) indicate that the image was acquired from a region outside the main panel; yellow boxes indicate regions of increased magnification. Black scale bar in (A) (for A–F), 100 µm; white scale bars in insets (A and E), 20 µm.
Figure 2Schematic design of the SSM. (A) The genetic crosses required for generating multiple independent m/m and sibling +/+ isolates, which are combined to produce the mutant DNA pool and the nonmutant sibling comparator DNA pool, respectively (also see Figure S3). (B) Simplified representations of sequenced chromosomes from the mutant pool (pink) and nonmutant sibling comparator pool (blue) are shown. Yellow lines indicate variants detected by WGS, and asterisks indicate variants that are homozygous in the mutant pool. Note that the depiction underestimates the true number of variants per chromosome. Dashed lines and purple asterisks indicate variants that are present in both the mutant pool and the nonmutant sibling comparator pool, which can be eliminated (subtracted) as candidate causal mutations. Note that subtraction will remove most or all variants on unlinked chromosomes, whereas homozygous variants very close to the causal mutation (red) may not be subtracted (black asterisks). (C) Venn diagram of subtracted variants (purple) along with the relatively small proportion of remaining candidate variants (pink) after application of the SSM.
Figure 3SSM workflow. Overview of the experimental and bioinformatical steps involved in the SSM/WGS method. For additional details, see text and Supplemental Methods, File S1.
Summary of SSM/WGS data
| Filtering Analysis (FA1–4) | Strain | Number of Variants Before SSM | Number of Variants After SSM | ||||
|---|---|---|---|---|---|---|---|
| Suppressed DNA Reads | Nonsuppressed Reads | Total | Change in Coding | Change in Coding Manually Filtered | |||
| Total | Change in Coding | Total | |||||
| FA1 100%Sup >0%Non-Sup | WY1208 | 2018 | 210 | 424,656 | 31 | 4 | 4 |
| WY1209 | 2075 | 222 | 471,857 | 42 | 4 | 2 | |
| WY1210 | 2096 | 230 | 1,021,954 | 37 | 3 | 2 | |
| WY1211 | 1898 | 218 | 860,417 | 19 | 2 | 2 | |
| WY1217 | 2063 | 208 | 969,292 | 36 | 0 | 0 | |
| FA2 ≥90%Sup >0%Non-Sup | WY1208 | 2652 (+31.4%) | 245 | 424,656 | 42 (+35.5%) | 4 | 4 |
| WY1209 | 2845 (+37.1%) | 260 | 471,857 | 45 (+7.1%) | 4 | 2 | |
| WY1210 | 2732 (+30.3%) | 258 | 1,021,954 | 46 (+24.3%) | 6 | 5 | |
| WY1211 | 2347 (+23.7%) | 237 | 860,417 | 29 (+52.6%) | 5 | 5 | |
| WY1217 | 2734 (+32.5.%) | 239 | 969,292 | 41 (+13.9%) | 1 | 1 | |
| FA3 100%Sup ≥10%Non-Sup | WY1208 | 2018 | 210 | 97,520 (−77.0%) | 38 (+22.6%) | 5 | 5 |
| WY1209 | 2075 | 222 | 117,834 (−75.0%) | 44 (+4.8%) | 5 | 3 | |
| WY1210 | 1898 | 230 | 74,586 (−92.6%) | 44 (+18.9%) | 3 | 2 | |
| WY1211 | 2063 | 218 | 91,174 (−89.4%) | 20 (+5.3%) | 2 | 2 | |
| WY1217 | 1891 | 208 | 79,897 (−91.8%) | 37 (+2.8%) | 0 | 0 | |
| FA4 ≥90%Sup ≥10%Non-Sup | WY1208 | 2652 | 245 | 97,520 | 52 (+64.5%) | 5 | 5 |
| WY1209 | 2845 | 260 | 117,834 | 47 (+21.6%) | 5 | 3 | |
| WY1210 | 2732 | 258 | 74,586 | 56 (+40.5%) | 6 | 5 | |
| WY1211 | 2347 | 237 | 91,174 | 30 (+59.3%) | 5 | 5 | |
| WY1217 | 2734 | 239 | 79,897 | 43 (+30.1%) | 1 | 1 | |
Sequencing was carried out on pooled independent isolates from suppressed and nonsuppressed strains as described in Materials and Methods. Numbers in parentheses in indicate positive (+) or negative (−) percentage changes for each strain relative to FA1. For more information see Supplemental Methods, File S1.
Includes nonsense, missense, frameshift, and splice site mutations.
For specific details on manual filtering see File S1.
Confirmation of recessive suppressor mutations
| Strain/Allele | Candidate Gene | Molecular Lesion | RNAi Phenocopy | CRISPR/Cas9 Phenocopy | Transgenic Rescue |
|---|---|---|---|---|---|
| WY1208 | C04A11.4 | G/A | N.D. | + | + |
| 13692151 X | |||||
| W494Stop | |||||
| WY1209 | F56D12.6 | C/T | + | + | N.D. |
| 1320072 II | |||||
| Q904Stop | |||||
| WY1211 | F48E8.5 | G/A | N.D. | + | + |
| 5452501 III | |||||
| G550E | |||||
| WY1217 | B0302.1 | 5 bp del. | + | + | + |
| 17191744 X | |||||
| S989F.S. |
For additional details on RNAi, CRISPR/Cas9, and transgenic rescue studies, see Materials and Methods, File S1 and Table S2. F.S. indicates frameshift. P values were derived for proportions using the N-1 chi-squared test.
“+” indicates that statistically significant suppression was observed following injection of WY1145 with corresponding dsRNAs.
“+” indicates that suppression of starting strain WY1145 was observed following editing of the corresponding loci. “N” indicates the number of suppressed independent CRISPR/Cas9-generated lines that were sequence verified.
“+” indicates that statistically significant rescue was observed following injection of corresponding suppressed strains with fosmids encoding the candidate loci. Note that in the case of suppressor mutations, rescued animals are no longer suppressed and are molting defective.
Figure 4EMS density mapping comparison in WY1208. EMS density mapping for the five suppressor strains was carried out using the CloudMap workflow on Galaxy (A) or using our variant identification workflow based on allele frequencies (B). The x axis indicates the location on each chromosome in megabases (Mb). The number of EMS signature SNPs are indicated on the y axis; red bars indicate a 0.5-Mb region, and gray bars indicate a 1.0-Mb region. Black arrows indicate the location of the identified causal mutations, and gray arrows indicate noncausal mutations identified by SSM. The blue bar in (B) indicates the implicated region on LGX that contained five coding-change candidates.